Invitrogen Launches Microarray to Study Non-Coding RNA

Invitrogen Corp. (NASDAQ: IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the first high-density microarray for the profiling of non-coding RNAs. The NCode Human and Mouse non-coding RNA microarrays consist of both non-coding RNA and messenger RNA (mRNA) content on the same array. The arrays are designed by Invitrogen and then manufactured by Agilent Technologies Inc. (NYSE: A), a technology leader in communications, electronics, life sciences and chemical analysis, using the company’s proprietary SurePrint technology.

Source: Agilent Technologies